Are These Warren Buffett Stocks a Buy at Beaten-Down Prices?

Warren Buffett's holding company Berkshire Hathaway (NYSE: BRK.A) (NYSE: BRK.B) has been able to produce jaw-dropping gains for its shareholders over the years by adhering to three basic principles:

Warren Buffett. Image source: The Motley Fool.

But even Berkshire Hathaway hasn't been able to escape the ravages of the marketwide meltdown over the COVID-19 coronavirus. This indiscriminate wave of selling, though, is undoubtedly creating some once-in-a-lifetime buying opportunities for patient investors. Within Warren Buffett's own portfolio, for instance, the healthcare giants Biogen (NASDAQ: BIIB), Johnson & Johnson (NYSE: JNJ), and Teva Pharmaceutical Industries (NYSE: TEVA) all appear to be trading at bargain basement prices after their steep declines over the past few weeks. Here's why. 

Continue reading

Source Fool.com